X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9442) 9442
Publication (1073) 1073
Book Review (197) 197
Book Chapter (13) 13
Dissertation (7) 7
Conference Proceeding (5) 5
Data Set (2) 2
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6750) 6750
oncology (6571) 6571
1st-line treatment (6358) 6358
index medicus (6122) 6122
chemotherapy (4765) 4765
female (4034) 4034
aged (3087) 3087
middle aged (3072) 3072
male (2983) 2983
cancer (2909) 2909
antineoplastic combined chemotherapy protocols - therapeutic use (2539) 2539
adult (2337) 2337
open-label (2302) 2302
treatment outcome (2146) 2146
colorectal cancer (1704) 1704
care and treatment (1687) 1687
metastasis (1615) 1615
1st-line therapy (1606) 1606
antineoplastic agents - therapeutic use (1518) 1518
fluorouracil (1444) 1444
colorectal neoplasms - drug therapy (1405) 1405
oxaliplatin (1381) 1381
bevacizumab (1363) 1363
phase-iii trial (1325) 1325
aged, 80 and over (1320) 1320
disease-free survival (1300) 1300
lung neoplasms - drug therapy (1256) 1256
survival (1204) 1204
pharmacology & pharmacy (1186) 1186
antineoplastic combined chemotherapy protocols - adverse effects (1162) 1162
colorectal neoplasms - pathology (1138) 1138
mutation (1136) 1136
prognosis (1117) 1117
research (1092) 1092
carcinoma, non-small-cell lung - drug therapy (1067) 1067
phase-ii trial (1040) 1040
leucovorin (1034) 1034
medicine & public health (1017) 1017
trial (1014) 1014
analysis (977) 977
neoplasm metastasis (970) 970
phase-iii (970) 970
drug therapy (950) 950
neoplasm staging (942) 942
therapy (915) 915
double-blind (908) 908
breast cancer (906) 906
lung cancer (906) 906
cancer therapies (905) 905
1st-line chemotherapy (901) 901
multicenter (897) 897
hematology, oncology and palliative medicine (895) 895
clinical trials (894) 894
combination (887) 887
gefitinib (856) 856
breast neoplasms - drug therapy (843) 843
erlotinib (843) 843
irinotecan (841) 841
randomized-trial (825) 825
cetuximab (818) 818
cisplatin (812) 812
capecitabine (802) 802
fluorouracil - administration & dosage (793) 793
lung cancer, non-small cell (789) 789
survival analysis (782) 782
health aspects (779) 779
retrospective studies (779) 779
cell lung-cancer (762) 762
phase-ii (746) 746
growth-factor receptor (743) 743
patients (739) 739
antineoplastic combined chemotherapy protocols - administration & dosage (723) 723
tumors (707) 707
paclitaxel (699) 699
survival rate (692) 692
docetaxel (687) 687
lung neoplasms - pathology (687) 687
adenocarcinoma (678) 678
deoxycytidine - analogs & derivatives (675) 675
metastatic colorectal-cancer (675) 675
epidermal growth factor (655) 655
surgery (652) 652
hematology (632) 632
antineoplastic agents (628) 628
lung neoplasms - genetics (617) 617
organoplatinum compounds - administration & dosage (606) 606
camptothecin - analogs & derivatives (600) 600
non-small cell lung cancer (588) 588
antimitotic agents (578) 578
carcinoma, non-small-cell lung - pathology (569) 569
animals (563) 563
5-fluorouracil (553) 553
cancer research (550) 550
carboplatin (550) 550
protein kinase inhibitors - therapeutic use (549) 549
randomized controlled trials as topic (542) 542
antibodies, monoclonal - therapeutic use (530) 530
deoxycytidine - administration & dosage (527) 527
randomized phase-iii (525) 525
carcinoma, non-small-cell lung - genetics (519) 519
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9212) 9212
French (114) 114
German (86) 86
Italian (8) 8
Polish (8) 8
Spanish (6) 6
Chinese (3) 3
Hungarian (3) 3
Korean (3) 3
Japanese (2) 2
Czech (1) 1
Portuguese (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9742, pp. 687 - 697
Journal Article
MEDICINE, ISSN 0025-7974, 05/2016, Volume 95, Issue 20, p. e3722
Journal Article
Cancer, ISSN 0008-543X, 10/2016, Volume 122, Issue 19, pp. 2952 - 2960
Journal Article
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 08/2014, Volume 9, Issue 8, pp. 1180 - 1186
Over the past decade, well tolerated second-line therapies for advanced non–small-cell lung cancer have been approved including erlotinib and pemetrexed in... 
Second line | Non–small-cell lung cancer | Erlotinib | Pemetrexed | Docetaxel | Predictors | Non-small-cell lung cancer | GEFITINIB | 1ST-LINE CHEMOTHERAPY | RANDOMIZED-TRIAL | PLUS CARBOPLATIN | MAINTENANCE THERAPY | PHASE-III TRIAL | SUPPORTIVE CARE | CISPLATIN | ONCOLOGY | RESPIRATORY SYSTEM | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Lung Neoplasms - ethnology | Age Factors | Guanine - analogs & derivatives | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Vinblastine - administration & dosage | Vinblastine - analogs & derivatives | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Retrospective Studies | Drug Therapy - trends | Carcinoma, Non-Small-Cell Lung - pathology | Survival Rate - trends | Deoxycytidine - administration & dosage | Carcinoma, Non-Small-Cell Lung - ethnology | British Columbia | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sex Factors | Glutamates - administration & dosage | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Platinum Compounds - administration & dosage | Asian Continental Ancestry Group - statistics & numerical data | Deoxycytidine - analogs & derivatives | Guanine - administration & dosage
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2017, Volume 2017, Issue 8, pp. CD004064 - CD004064
Journal Article